Delivery Order SPE2DB25D3504-SPE2DB25FVVSP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on September 12, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by October 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $19,808.64 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 13, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract issued under a child delivery order structure. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order derives from AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Varivax vaccine with diluents, with a contract ceiling value of $268,348.60. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The work is scheduled for completion by September 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,846.51 for Varivax vaccine with diluents on September 8, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed price, non-competitive delivery order with performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply relationship with DLA, leveraging the company's extensive capabilities as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents under a firm fixed-price contract valued at $1,032.11. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 16, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,265.05 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 12, 2025, with an ultimate completion date of October 3, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 21, 2025, with a ceiling value of $2,085.12. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $13,553.28 under a firm fixed price contract type. The delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this requirement as a child contract under its larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $66,055.04 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on August 7, 2025, with an ultimate completion date of August 28, 2025, carries firm fixed pricing and represents a competitive award with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this delivery order, which falls under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents under a firm fixed price contract with a ceiling value of $1,053.01. The delivery order, issued on September 10, 2025, is scheduled for ultimate completion by October 1, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVVSPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,042.56 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The contract, issued on July 28, 2025, with an ultimate completion date of August 18, 2025, utilizes firm fixed-price pricing and requires performance at the contractor's Conshohocken, Pennsylvania facility. This is an unset-aside award made through competitive procurement, reflecting AmerisourceBergen's established capability to meet federal vaccine supply requirements. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply vaccines, medications, and medical supplies to support military healthcare programs worldwide. This particular delivery order for Varivax vaccine represents one of numerous pharmaceutical transactions executed under this strategic contract vehicle, supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/28/25 |